Biotechnology company NanoString partners with Merck to create test for anti-cancer drug by Madeline Vuong on February 29, 2016February 29, 2016 at 2:57 pm NanoString Technologies, a Seattle-based company that researches how genetic and immune markers can be used to predict patient response to different cancer therapies, announced today that it will join pharmaceutical… Read More